Macrogenics (MGNX) Non Operating Income (2012 - 2022)

Macrogenics (MGNX) reported Non Operating Income of $819000.0 for Q4 2022, up 282.71% year-over-year from $214000.0 in Q4 2021, and up 476.76% quarter-over-quarter from $142000.0 in Q3 2022.

Macrogenics (MGNX) Non Operating Income (2012 - 2022) Analysis & Trends

Macrogenics (MGNX) has 11 years of Non Operating Income data on file, last reported at $819000.0 in Q4 2022.

  • Non Operating Income for Q4 2022 came in at $819000.0, up 282.71% year-over-year; the trailing twelve-month figure through Dec 2022 was $1.7 million (up 144.12% YoY), and the FY2025 annual result was $6.1 million, down 35.71% from the prior year.
  • Non Operating Income improved to $819000.0 in Q4 2022 per MGNX's latest filing, from $142000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $21.2 million in Q2 2019 and troughed at -$6.7 million in Q3 2019.
  • A 5-year average of $1.4 million and a median of $384500.0 in 2020 frame the typical range for Non Operating Income.
  • On a YoY basis, Non Operating Income climbed as much as 1881.5% in 2019 and fell as far as 785.85% in 2019.
  • A 5-year view of Non Operating Income shows it stood at -$3.0 million in 2018, then jumped by 378.46% to $8.3 million in 2019, then plunged by 99.0% to $83000.0 in 2020, then jumped by 157.83% to $214000.0 in 2021, then jumped by 282.71% to $819000.0 in 2022.
  • Business Quant data shows MGNX's Non Operating Income at $819000.0 in Q4 2022, $142000.0 in Q3 2022, and $504000.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 444,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 9.35 Mn
10 Macrogenics 260.14 Mn 193.63 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 819,000.00
Sep 30, 2022 142,000.00
Jun 30, 2022 504,000.00
Mar 31, 2022 195,000.00
Dec 31, 2021 214,000.00
Sep 30, 2021 101,000.00
Jun 30, 2021 344,000.00
Mar 31, 2021 21,000.00
Dec 31, 2020 83,000.00
Sep 30, 2020 92,000.00
Jun 30, 2020 425,000.00
Mar 31, 2020 721,000.00
Dec 31, 2019 8.26 Mn
Sep 30, 2019 -6.69 Mn
Jun 30, 2019 21.20 Mn
Mar 31, 2019 2.60 Mn
Dec 31, 2018 -2.97 Mn
Sep 30, 2018 975,000.00
Jun 30, 2018 1.07 Mn
Mar 31, 2018 674,000.00